Summary: Featuring articles on an invasive or conservative strategy for stable coronary disease, health-status outcomes in the ISCHEMIA trial, physical therapy vs. glucocorticoids for osteoarthritis of the knee, selumetinib for plexiform neurofibromas, and resolving inflammation in asthma and beyond; a review article on alpha1–antitrypsin deficiency; a case report of a man with facial droop, dysarthria, and kidney failure; and Perspective articles on standing up against gender bias and harassment, on hospital mergers and conscience-based objections, on a new era for mind–body medicine, and on chart warfare.
